Wellington Management Group’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-182,245
| Closed | -$8.75M | – | 2056 |
|
|
2020
Q1 | $8.75M | Sell |
182,245
-74,194
| -29% | -$3.45M | ﹤0.01% | 1068 |
|
|
2019
Q4 | $12M | Sell |
256,439
-4,058,508
| -94% | -$179M | ﹤0.01% | 1121 |
|
|
2019
Q3 | $102M | Sell |
4,314,947
-865,221
| -17% | -$25.6M | 0.02% | 537 |
|
|
2019
Q2 | $156M | Buy |
5,180,168
+36,269
| +0.7% | +$831K | 0.03% | 441 |
|
|
2019
Q1 | $115M | Sell |
5,143,899
-114,053
| -2% | -$2.45M | 0.03% | 508 |
|
|
2018
Q4 | $95.7M | Buy |
5,257,952
+2,378,520
| +83% | +$37.3M | 0.02% | 523 |
|
|
2018
Q3 | $52.1M | Buy |
2,879,432
+3,795
| +0.1% | +$45K | 0.01% | 788 |
|
|
2018
Q2 | $28.6M | Sell |
2,875,637
-31,860
| -1% | -$220K | 0.01% | 969 |
|
|
2018
Q1 | $15.4M | Buy |
2,907,497
+140,254
| +5% | +$1M | ﹤0.01% | 1157 |
|
|
2017
Q4 | $23.5M | Buy |
2,767,243
+474,202
| +21% | +$5.83M | 0.01% | 1022 |
|
|
2017
Q3 | $33.5M | Buy |
2,293,041
+187,977
| +9% | +$2.84M | 0.01% | 886 |
|
|
2017
Q2 | $39.4M | Buy |
2,105,064
+473,635
| +29% | +$10.7M | 0.01% | 805 |
|
|
2017
Q1 | $34.7M | Buy |
1,631,429
+56,450
| +4% | +$1.08M | 0.01% | 848 |
|
|
2016
Q4 | $23.9M | Buy |
+1,574,979
| New | +$21.4M | 0.01% | 946 |
|
